the aid library

Sort by:

Direction:

HIVi/AIDSi ravi ja hooldus Eestis

D. Raben; S. F. Jakobsen; F. Nakagawa; et al. Maailma Terviseorganisatsioon (Euroopa); WHO Collaborating Centre on HIV and Viral Hepatitis; Centre for Health & Infectious Disease Research (CHIP) (2014) C_WHO

Hindamisaruanne Juuni 2014

Download (81)

View PDF (128)

HIV/AIDS treatment and care in Estonia

D. Raben; S. F. Jakobsen; F. Nakagawa; et al. World Health Organization (Europe); WHO Collaborating Centre on HIV and Viral Hepatitis; Centre for Health & Infectious Disease Research (CHIP) (2014) C_WHO

Download (39)

View PDF (42)

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward

Minja, N.W.; Nakagaayi, D.; Aliku, T. et al. Frontiers in Cardiovascular Medicine (2022) CC

In 2015, the United Nations set important targets to reduce premature cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD burden and has one of the highest risks of dying from non-communicable diseases (NCDs) worldwide. There is currently an epide...miological transition on the continent, where NCDs is projected to outpace communicable diseases within the current decade. Unchecked increases in CVD risk factors have contributed to the growing burden of three major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age standardized disability-adjusted life years (DALYs) due to hypertensive heart disease (HHD) were recorded in Africa. The contributory causes of heart failure are changing—whilst HHD and cardiomyopathies still dominate, ischemic heart disease is rapidly becoming a significant contributor, whilst rheumatic heart disease (RHD) has shown a gradual decline. In a continent where health systems are traditionally geared toward addressing communicable diseases, several gaps exist to adequately meet the growing demand imposed by CVDs. Among these, high-quality research to inform interventions, underfunded health systems with high out-of-pocket costs, limited accessibility and affordability of essential medicines, CVD preventive services, and skill shortages. Overall, the African continent progress toward a third reduction in premature mortality come 2030 is lagging behind. More can be done in the arena of effective policy implementation for risk factor reduction and CVD prevention, increasing health financing and focusing on strengthening primary health care services for prevention and treatment of CVDs, whilst ensuring availability and affordability of quality medicines. Further, investing in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on interventions. This review summarizes the current CVD burden, important gaps in cardiovascular medicine in Africa, and further highlights priority areas where efforts could be intensified in the next decade with potential to improve the current rate of progress toward achieving a 33% reduction in CVD mortality. more

Download (116)

View PDF (174)

Предотвращение самоубийств - Глобальный императив

Shekhar Saxena , Etienne Krug, Oleg Chestnov et al. World Health Organization (WHO) (2014) C_WHO

Цель данного доклада – стать ресурсом, позволяющим руководителям и другим заинтересованным сторонам рассматри-вать предупреждение самоубийств как императив. То�... more

Download (103)

View PDF (1000)

Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended

H. Adler, Gould, S.; Hine, P.; et al. The Lancet (2022) CC

Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated eff... more

Download (58)

View PDF (56)

WHF Roadmap for Digital Health in Cardiology

Tromp, J.; Jindal, D.; Redfern, J. et al. Global Heart (2022) CC

ABSTRACT More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del... more

Download (168)

View PDF (200)

сельское население (rural- russian edition)

FG Consulting Group, C. Daniels, C. Smyth et al. UNOPS, Stop TB Partnership et al. (2019) C1

Глобальная статистика свидетельствует о том, что бремя туберкулеза более актуально в городских регионах. Тем не менее, в тех странах, где большая часть населения п�... more

Download (247)

View PDF (369)

Rural populations (Russian edition)

Stop TB Partnership; UNOPS; END TB (2017) C1

Key populations brief Accessed 2017 СЕЛЬСКОЕ НАСЕЛЕНИЕ ОСНОВНЫЕ ЗАТРОНУТЫЕ ГРУППЫ НАСЕЛЕНИЯ. КРАТКОЕ РУКОВОДСТВО.

Download (121)

View PDF (179)

J12. Wellbeing: identification and prevention of burnout, depression and suicide among child mental health clinicians

Frances Javier, Julie Chilton & Andrés Martin IACAPAP (2015) C1

Download (56)

View PDF (43)

Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes

Park, J.J. Diabetes & Metabolism Journal (2021) CC

The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit... more

Download (104)

View PDF (348)

Preventable Epilepsy: Taenia Solium Infection Burdens Economies, Societies and Individuals

World Health Organization WHO (2016) C_WHO

Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers. ... more

Download (132)

View PDF (175)

HIV drug resistance strategy, 2021 update

World Health Organization WHO (2021) C_WHO

Download (187)

View PDF (201)

HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis

World Health Organization WHO (2020) C_WHO

WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches. HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i... more

Download (146)

View PDF (151)

Standard treatment guidelines oncology India

Ministry of Health & Family Welfare, India (2020) C1

Accessed Febr. 6, 2020

Download (1839)

View PDF (2708)

Landscape for HIV rapid diagnostic tests for HIV self-testing - 4th edition

World Health Organization (WHO); UNITAID World Health Organization (WHO); UNITAID (2018) C2

July 2018 This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United... more

Download (135)

View PDF (145)

Market and technology landscape HIV rapid diagnostic tests for self-testing - 4th Edition

O. Ajose; C. Pérez Casas; H. Ingold; et al. Unitaid (Innovation in Global Health); World Health Organization (WHO) (2018) C2

July 2018

Download (107)

View PDF (145)

Knowing your status: then and now - Realizing the potential of HIV self-testing

Karin Hatzold; E. Corbett; H. Ingold; et al. Unitaid (Innovation in Global Health); World Health Organization (WHO); HIV Self-Testing Africa Initiative (2018) C2

30th World AIDS Day Report STAR Initiative, Unitaid and World Health Organization December 2018

Download (327)

View PDF (536)

Indigenous peoples

M. Smelyanskaya, C. Daniels, et al. Stop TB Partnership; UNOPS; END TB (2017) C1

Key populations brief.

Download (315)

View PDF (360)

Populations Rurales - En situation de pauvreté

Stop TB Partnership; UNOPS; END TBc1 (2017) C1

Rapport sur les populations clès Accessed November 2017

Download (269)

View PDF (302)

Rural populations

Stop TB Partnership; UNOPS; END TB (2017) C1

Key populations brief Accessed 2017

Clinical features and management of human monkeypox: a retrospective observational study in the UK recommended

Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended